<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

NANS 2019 Preview: SmartTRAK Interviews Todd Sitzman, MD

Posted by Anne Staylor on 1/14/19 10:00 AM

In an interview with SmartTRAK, B. Todd Sitzman, MD, MPH, President of the North American Neuromodulation Society (NANS), provides a preview of the educational opportunities, key research and emerging technologies that will be at the NANS 22nd Annual meeting to be held January 17-20, 2019 in Las Vegas, NV. Dr. Sitzman expects NANS 2019 to be the biggest meeting yet for the premier neuromodulation society, with up to 3000 attendees and 300+ abstracts presented, organized around the theme of “The Science Behind Successful Outcomes.”

To find out more about the meeting, click on the video below to listen to SmartTRAK’s interview with Dr. Sitzman, recorded via Skype from his office in Hattiesburg, Mississippi (11:53 minutes). 

Read More

Topics: Neuromodulation, SmartTRAK Interviews

An Interview with Medtronic's Matt Thomas

Posted by Anne Staylor on 11/6/18 11:00 AM

Medtronic’s Matt Thomas discusses the Company’s strategies for driving growth in spinal cord stimulation and plans for innovation in an interview with SmartTRAK at ASIPP 2018.

Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL

Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)

To receive a downloadable transcript, click the button below...

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK Interviews Cerapedics:  i-FACTOR, a Novel Bone Graft

Posted by Kim French on 8/15/18 10:07 AM

Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft substitutes and the uniqueness of i‑FACTOR Peptide Enhanced Bone Graft, a small peptide technology in an interview with Kim French, Sr. Analyst, SmartTRAK Orthbio.

A transcript of SmartTRAK's interview with Glen Kashuba and Jeff Marx is below, or click on the following video to listen to the interview.

Read More

Topics: Orthopedics-OrthoBio, SmartTRAK Interviews

SmartTRAK Interviews Nick Deeter of Wishbone Medical - Pediatric Orthopedics

Posted by Lisa Mahan on 7/13/18 9:24 AM

Interest in the $2.5B market for pediatric orthopedics has been growing as companies like Wishbone Medical develop an increasing number of anatomically appropriate implants for kids in indications ranging from spinal deformities to hip replacements. Lisa Mahan, VP  Content Development, Orthopedics at SmartTRAK recently interviewed Nick Deeter, Founder, Chairman of the Board, and CEO of WishBone Medical, who has been a pioneer in this market segment.

Read More

Topics: SmartTRAK Interviews

phenox Aiming To Bring Novel Stroke Devices to the US Market

Posted by Anne Staylor on 6/8/18 3:52 PM

In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

What’s Next for Nuvectra? An Interview with CEO Scott Drees

Posted by Anne Staylor on 3/13/18 11:01 AM

Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.

A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)

Read More

Topics: Neuromodulation, SmartTRAK Interviews

High Frequency SCS for Upper Limb and Neck Pain: An Interview with Kas Amirdelfan, MD

Posted by Anne Staylor on 1/18/18 11:33 AM

Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study

Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.) 

A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

The Future of NeuroInterventional Surgery: A SmartTRAK Interview with Don Frei, MD

Posted by Anne Staylor on 11/9/17 7:01 PM

Society of NeuroInterventional Surgery (SNIS) President Donald F. Frei, MD talked with SmartTRAK at the SNIS 14th Annual Meeting regarding the future of neurointerventional surgery. 

Don Frei, MD, President of the Society of NeuroInterventional Surgery (SNIS), discusses key studies, trends, and technologies affecting the market for mechanical thrombectomy devices in an interview with SmartTRAK at the SNIS 14th Annual Meeting July 24-27, 2017 in Colorado Springs, CO.

A transcript of SmartTRAK’s interview with Don Frei, MD, is below. To listen to the audio interview recorded live at SNIS 2017, click here

Read More

Topics: Neurotherapies, SmartTRAK Interviews

Smarttrak Interview: Dr. David Armstrong on Fat Grafting for Reducing Diabetic Foot Ulcer  Recurrence

Posted by Susan Paquette on 9/14/17 9:00 AM

Reducing the recurrence of diabetic foot ulcers (DFU) or increasing ulcer free days is critical for patients with diabetes, as recurrence rates are 40% at one year, 66% at three years, and 75% at five years. At the DF Con meeting in Houston in March, BioMedGPS interviewed David G. Armstrong, DMP, MD, PhD, regarding his research on the use of fat grafting as a means to reduce recurrence of DFUs. Today, fat grafting is being rapidly adopted in plastic and reconstructive surgery, but is now being explored for care of the diabetic foot.

Read More

Topics: Advanced Wound Care-Wound Biologics, SmartTRAK Interviews

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts